AMGN three-lens brief
Evidence-based stock research on AMGN. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 18.2pp over 30 days. · Debt-to-equity of 623.8 — balance-sheet-heavy.
- Underperforming SPY by 18.2pp over 30 days.
- Debt-to-equity of 623.8 — balance-sheet-heavy.
- Reported earnings on 2026-04-30.
- Ex-dividend date 2026-05-15.
AMGN closed at $334.55 (-0.52%) as of 2026-05-13. Market cap: $180.66B. P/E (trailing) 23.3. Concerns: underperforming SPY by 18.2pp over 30 days.; debt-to-equity of 623.8 — balance-sheet-heavy.. Last quarter: Revenue $8.62B, net income $1.82B, free cash flow $7.44B.
Why three lenses on AMGN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMGNacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMGN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMGN brief"></iframe>